Oral valacyclovir and topical clobetasol combo most effective in herpes labialis management

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-05-02 14:30 GMT   |   Update On 2023-05-03 10:14 GMT
Advertisement

Combination therapy of oral valacyclovir and topical clobetasol is the most effective in herpes labialis management suggests a new study published in the Journal of Evidence-Based Dental Practice

A study was done to compare the relative efficacy and safety of antiviral agents used in the prevention and management of herpes labialis through a network meta-analysis of clinical trials.

A systematic search was performed in Ovid Medline PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus and Clinicaltrials.gov for randomized controlled trials (RCTs) reporting a comparison of antiviral agents in the management and prevention of herpes labialis in healthy/immunocompetent adults. The data extracted from the selected RCTs were assessed and a network meta-analysis (NMA) was performed. The interventions were ranked according to the surface under the cumulative ranking (SUCRA).

Advertisement

Results

  • A total of 52 articles were included for qualitative synthesis and for the quantitative part, 26 articles were analyzed for the primary treatment outcome and 7 studies were analyzed for the primary prevention outcome.

  • The combination therapy of oral valacyclovir and topical clobetasol was the best ranked with a mean reduction in healing time of -3.50 followed by vidarabine monophosphate of -3.22

  • No significant inconsistencies, heterogeneity, and publication bias were reported for TTH outcome analysis.

  • For primary prevention outcomes, only 7 RCTs fulfilled the inclusion criteria, and none of the interventions was shown to be superior to each other.

  • The absence of adverse events was reported by 16 studies, whereas other studies reported mild side effects only.

NMA highlighted that several agents were effective in the management of herpes labialis among which the combination of oral valacyclovir with topical clobetasol therapy was the most effective in reducing the time to heal. However, further studies are required to determine which intervention is the most effective in preventing the recurrence of herpes labialis.

Reference:

Kim Hoe Koe, Sajesh K Veettil, Mari Kannan Maharajan, M Sakil Syeed, Athira Balakrishnan Nair, Divya Gopinath. COMPARATIVE EFFICACY OF ANTIVIRAL AGENTS FOR PREVENTION AND MANAGEMENT OF HERPES LABIALIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. Journal of Evidence-Based Dental Practice, Volume 23, Issue 1, 2023, 101778, ISSN 1532-3382. https://doi.org/10.1016/j.jebdp.2022.101778.

(https://www.sciencedirect.com/science/article/pii/S1532338222001014)

Keywords:

Combination, therapy, oral valacyclovir, topical, clobetasol, most, effective, herpes labialis, management, Journal of Evidence-Based Dental Practice, Kim Hoe Koe, Sajesh K Veettil, Mari Kannan Maharajan, M Sakil Syeed, Athira Balakrishnan Nair, Divya Gopinath.

Tags:    
Article Source : Journal of Evidence-Based Dental Practice

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News